Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Baicalin regulates the dopamine system to control the core symptoms of ADHD.

Zhou R, Wang J, Han X, Ma B, Yuan H, Song Y.

Mol Brain. 2019 Feb 8;12(1):11. doi: 10.1186/s13041-019-0428-5.

2.

Saikosaponin A Alleviates Symptoms of Attention Deficit Hyperactivity Disorder through Downregulation of DAT and Enhancing BDNF Expression in Spontaneous Hypertensive Rats.

Jichao S, Xinmin H, Xianguo R, Dongqi Y, Rongyi Z, Shuang L, Yue Y, Yuchen S, Jingnan Y.

Evid Based Complement Alternat Med. 2017;2017:2695903. doi: 10.1155/2017/2695903. Epub 2017 Feb 15.

3.

[Effect of baicalin on behavioral characteristics of rats with attention deficit hyperactivity disorder].

Zhou RY, Han XM, Wang JJ, Yuan HX, Sun JC, You Y, Song YC.

Zhongguo Dang Dai Er Ke Za Zhi. 2017 Aug;19(8):930-937. Chinese.

4.

Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.

Kim H, Heo HI, Kim DH, Ko IG, Lee SS, Kim SE, Kim BK, Kim TW, Ji ES, Kim JD, Shin MS, Choi YW, Kim CJ.

Neurosci Lett. 2011 Oct 17;504(1):35-9. doi: 10.1016/j.neulet.2011.08.052. Epub 2011 Aug 31.

PMID:
21907264
5.

Homer expression in the hippocampus of an animal model of attention-deficit/hyperactivity disorder.

Hong Q, Wang YP, Zhang M, Pan XQ, Guo M, Li F, Tong ML, Chen RH, Guo XR, Chi X.

Mol Med Rep. 2011 Jul-Aug;4(4):705-12. doi: 10.3892/mmr.2011.479. Epub 2011 Apr 26.

PMID:
21523321
6.

Prepuberal intranasal dopamine treatment in an animal model of ADHD ameliorates deficient spatial attention, working memory, amino acid transmitters and synaptic markers in prefrontal cortex, ventral and dorsal striatum.

Ruocco LA, Treno C, Gironi Carnevale UA, Arra C, Mattern C, Huston JP, de Souza Silva MA, Nikolaus S, Scorziello A, Nieddu M, Boatto G, Illiano P, Pagano C, Tino A, Sadile AG.

Amino Acids. 2014 Sep;46(9):2105-22. doi: 10.1007/s00726-014-1753-8. Epub 2014 May 27.

PMID:
24862315
7.
8.

Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.

Kodama T, Kojima T, Honda Y, Hosokawa T, Tsutsui KI, Watanabe M.

J Neurosci. 2017 Mar 1;37(9):2387-2394. doi: 10.1523/JNEUROSCI.2155-16.2017. Epub 2017 Feb 2.

9.

Swimming exercise alleviates the symptoms of attention-deficit hyperactivity disorder in spontaneous hypertensive rats.

Ko IG, Kim SE, Kim TW, Ji ES, Shin MS, Kim CJ, Hong MH, Bahn GH.

Mol Med Rep. 2013 Aug;8(2):393-400. doi: 10.3892/mmr.2013.1531. Epub 2013 Jun 19.

PMID:
23779147
11.

Methylphenidate administration reverts attentional inflexibility in adolescent rats submitted to a model of neonatal hypoxia-ischemia: Predictive validity for ADHD study.

Miguel PM, Deniz BF, Confortim HD, Bronauth LP, de Oliveira BC, Alves MB, Silveira PP, Pereira LO.

Exp Neurol. 2019 Feb 13. pii: S0014-4886(18)30625-3. doi: 10.1016/j.expneurol.2019.02.004. [Epub ahead of print]

PMID:
30771298
12.

Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.

Somkuwar SS, Kantak KM, Dwoskin LP.

J Neurosci Methods. 2015 Aug 30;252:55-63. doi: 10.1016/j.jneumeth.2015.02.002. Epub 2015 Feb 11.

13.

Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD).

Moon SJ, Kim CJ, Lee YJ, Hong M, Han J, Bahn GH.

PLoS One. 2014 Oct 1;9(10):e108918. doi: 10.1371/journal.pone.0108918. eCollection 2014.

14.

The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens.

Miller EM, Pomerleau F, Huettl P, Russell VA, Gerhardt GA, Glaser PE.

Neuropharmacology. 2012 Dec;63(8):1327-34. doi: 10.1016/j.neuropharm.2012.08.020. Epub 2012 Sep 1.

15.

Prefrontal cortex Homer expression in an animal model of attention-deficit/hyperactivity disorder.

Hong Q, Zhang M, Pan XQ, Guo M, Li F, Tong ML, Chen RH, Guo XR, Chi X.

J Neurol Sci. 2009 Dec 15;287(1-2):205-11. doi: 10.1016/j.jns.2009.07.024. Epub 2009 Aug 26.

PMID:
19709672
16.

Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.

Harvey RC, Sen S, Deaciuc A, Dwoskin LP, Kantak KM.

Neuropsychopharmacology. 2011 Mar;36(4):837-47. doi: 10.1038/npp.2010.223. Epub 2010 Dec 8.

17.

Effects of developmental methylphenidate (MPH) treatment on monoamine neurochemistry of male and female rats.

Panos JJ, O'Callaghan JP, Miller DB, Ferguson SA.

Neurotoxicol Teratol. 2014 Sep-Oct;45:70-4. doi: 10.1016/j.ntt.2014.08.001. Epub 2014 Aug 15.

PMID:
25132048
18.

Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.

Roessner V, Sagvolden T, Dasbanerjee T, Middleton FA, Faraone SV, Walaas SI, Becker A, Rothenberger A, Bock N.

Neuroscience. 2010 Jun 2;167(4):1183-91. doi: 10.1016/j.neuroscience.2010.02.073. Epub 2010 Mar 6.

PMID:
20211696
19.

Glucocorticoids/glucocorticoid receptors effect on dopaminergic neurotransmitters in ADHD rats.

Chen Y, Zheng X, Xie L, Huang L, Ke Z, Zheng J, Lu H, Hu J.

Brain Res Bull. 2017 May;131:214-220. doi: 10.1016/j.brainresbull.2017.04.013. Epub 2017 Apr 27.

PMID:
28458039

Supplemental Content

Support Center